ClinVar Miner

Submissions for variant NM_001927.4(DES):c.893C>T (p.Ser298Leu)

gnomAD frequency: 0.00014  dbSNP: rs62636491
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000171830 SCV000055125 uncertain significance Primary dilated cardiomyopathy 2018-04-05 criteria provided, single submitter research
Eurofins Ntd Llc (ga) RCV000056814 SCV000335234 uncertain significance not provided 2015-09-11 criteria provided, single submitter clinical testing
GeneDx RCV000056814 SCV000491114 uncertain significance not provided 2019-04-11 criteria provided, single submitter clinical testing Reported previously in a patient with DCM but no reported myopathy; however segregation data were not provided (Taylor et al., 2007); Functional studies show disruption of desmin filament assembly in the presence of the S298L variant (Taylor et al., 2007); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30564623, 23299917, 23861362, 17325244, 23143191, 22337857, 20474083, 27896284, 29926427)
Labcorp Genetics (formerly Invitae), Labcorp RCV000466593 SCV000552184 uncertain significance Desmin-related myofibrillar myopathy 2024-01-15 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 298 of the DES protein (p.Ser298Leu). This variant is present in population databases (rs62636491, gnomAD 0.03%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 17325244, 23861362). ClinVar contains an entry for this variant (Variation ID: 66423). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DES protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Illumina Laboratory Services, Illumina RCV001142372 SCV001302806 uncertain significance Dilated cardiomyopathy 1I 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Illumina Laboratory Services, Illumina RCV000466593 SCV001302807 benign Desmin-related myofibrillar myopathy 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.
Illumina Laboratory Services, Illumina RCV001143228 SCV001303735 benign Neurogenic scapuloperoneal syndrome, Kaeser type 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.
Athena Diagnostics RCV000056814 SCV001475073 uncertain significance not provided 2020-03-18 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000056814 SCV003829066 uncertain significance not provided 2022-08-19 criteria provided, single submitter clinical testing
Ambry Genetics RCV003352761 SCV004056210 uncertain significance Cardiovascular phenotype 2021-06-16 criteria provided, single submitter clinical testing The c.893C>T (p.S298L) alteration is located in exon 4 (coding exon 4) of the DES gene. This alteration results from a C to T substitution at nucleotide position 893, causing the serine (S) at amino acid position 298 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Epithelial Biology; Institute of Medical Biology, Singapore RCV000056814 SCV000087927 not provided not provided no assertion provided not provided
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital RCV000735983 SCV000864165 likely pathogenic Cardiomyopathy 2019-01-03 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.